etiolog
kawasaki
diseas
kd
remain
unknown
despit
sever
year
dedic
research
direct
recent
coronaviru
infect
genet
polymorph
implic
sinc
first
descript
diseas
chang
diagnost
criteria
except
newer
recommend
fever
least
instead
day
durat
recent
echocardiographi
criteria
laboratori
criteria
ad
aid
diagnosi
incomplet
kd
histor
diagnost
criteria
present
call
incomplet
form
kd
oppos
atyp
form
kd
word
atyp
reserv
unusu
present
kd
hemophagocyt
syndrom
nerv
palsi
treatment
kd
includ
infus
high
dose
immunoglobulin
patient
nonrespons
immunoglobulin
therapi
label
immunoglobulin
resist
kd
treatment
immunoglobulin
resist
kd
challeng
new
therapi
tri
success
late
outcom
decad
treat
patient
recent
publish
concern
increas
risk
prematur
atherosclerosi
patient
childhood
kd
coronari
arteri
abnorm
indian
j
pediatr
kawasaki
diseas
kd
acut
system
vascul
predilect
coronari
arteri
potenti
aneurysm
format
diseas
first
describ
dr
tomisaku
kawasaki
japanes
children
continu
preval
major
pediatr
disord
becom
lead
caus
acquir
heart
diseas
children
mani
nation
incid
acut
rheumat
fever
decreas
avail
echocardiographi
awar
kd
physician
also
made
impact
earli
detect
treatment
diseas
kd
includ
differenti
diagnosi
fever
unknown
origin
children
differenti
diagnosi
undiagnos
kd
must
consid
young
adult
patient
aneurysm
earli
atherosclerot
lesion
without
signific
famili
histori
risk
factor
earli
purpos
paper
present
review
etiolog
clinic
featur
treatment
kd
emphasi
current
state
art
season
occurr
diseas
winter
earli
spring
unit
state
endem
epidem
outbreak
low
incid
kd
infant
month
age
matern
antibodi
present
year
age
immun
variou
organ
develop
portal
entri
may
respiratori
tract
gastrointestin
tract
skin
variou
infecti
agent
detect
children
kd
includ
leptospira
yersinia
pseudotuberculosi
chlamydia
parvoviru
b
epsteinbarr
viru
recent
coronaviru
immunocompromis
patient
human
immunodefici
viru
chickenpox
infect
increas
incid
kd
bacteria
produc
toxin
act
superantigen
streptococcu
staphylococcu
also
detect
children
kd
higher
incid
seen
febril
children
tm
addit
children
kd
similar
abil
mount
antibodi
respons
toxin
compar
children
without
kd
unlik
women
toxic
shock
syndrom
defect
serolog
respons
toxic
shock
syndrom
henc
develop
toxic
shock
syndrom
genet
predisposit
hypothes
risk
occurr
increas
famili
histori
kd
increas
risk
twin
genet
polymorph
vascular
endotheli
growth
factor
receptor
ligand
convert
enzym
implic
coronari
arteri
aneurysm
format
kd
earli
stage
panvascul
increas
perivascular
inflammatori
cell
initi
neutrophil
later
macrophag
tlymphocyt
inflammatori
endotheli
subendotheli
edema
initi
later
damag
intern
elast
lamina
develop
aneurysm
medial
smooth
muscl
cell
prolifer
eventu
fibrosi
begin
scar
format
ongo
prolifer
medial
smooth
muscl
cell
earli
degener
acut
stage
kawasaki
diseas
respons
late
stenosi
coronari
arteri
acut
vascular
inflamm
mark
immun
activ
hallmark
diseas
activ
endothelium
increas
level
sever
proinflammatori
cytokin
serum
level
seselectin
solubl
cell
adhes
molecul
increas
result
activ
endotheli
cell
presenc
inflamm
tissu
destruct
enzym
elastas
matrix
metalloproteinas
collagenolyt
cystein
proteas
increas
kd
involv
breakdown
intern
elast
lamina
vascular
wall
remodel
progress
vascular
injuri
serum
tissu
cystatin
c
exert
protect
role
vascular
remodel
level
get
sever
depress
significantli
lower
serum
level
seen
patient
dilat
aorta
acut
kd
appear
macrophag
play
import
role
produc
vascul
mechan
releas
proteolyt
enzym
possibl
decreas
macrophag
activ
immunoglobulin
subsequ
decreas
elastolyt
proteas
key
therapi
kd
rapid
decreas
proinflammatori
cytokin
immedi
immunoglobulin
infus
zl
may
mechan
symptom
improv
within
hour
infus
kd
acut
febril
ill
childhood
mostli
seen
children
younger
year
age
male
predomin
male
femal
ratio
fever
usual
high
spike
persist
recur
sever
week
treat
diffus
erythmat
rash
occur
macular
maculopapular
rare
micropustular
rash
mimic
diseas
entiti
may
appear
urticari
erythemamultiformelik
like
sandpap
rash
scarlet
fever
rash
present
extrem
trunk
perin
region
subacut
phase
desquam
seen
perin
periungu
region
reinflamm
bacil
calmetteguerin
inocul
site
occur
site
becom
indur
erythemat
nonpurul
bulbar
conjunct
parent
usual
describ
pink
eye
larg
firm
nonfluctu
cervic
inguin
mass
occur
due
lymphaden
usual
conglomer
multipl
smaller
lymph
node
lip
may
initi
becom
erythemat
swollen
later
fissur
peel
crack
bleed
may
occur
oral
mucosa
may
also
becom
erythemat
well
tongu
becom
erythemat
appear
like
strawberri
tongu
similar
seen
scarlet
fever
initi
swell
palm
sole
may
occur
along
erythema
tender
raynaud
phenomenon
peripher
gangren
also
describ
kd
arthralgia
arthriti
pauciarticular
polyarticular
also
occur
involv
small
larg
joint
subacut
stage
kd
periungu
peel
toe
finger
seen
beau
line
transvers
groov
across
nail
may
occur
stage
kd
caus
pancard
vascul
major
compon
endocardium
myocardium
pericardium
less
sever
involv
coronari
arteri
predominantli
involv
obstruct
vessel
respons
major
cardiac
symptom
blood
vessel
iliac
axillari
arteri
also
involv
occasion
unless
coronari
vessel
obstruct
cardiac
find
mild
usual
transitori
tachycardia
due
fever
andor
myocard
gallop
myocard
pericardi
rub
distant
heart
sound
pericardi
effus
new
murmur
mitral
regurgit
aortic
insuffici
patient
usual
complain
abdomin
pain
may
anorexia
mild
dysfunct
liver
may
occur
hepatomegali
jaundic
hydrop
gall
bladder
vomit
diarrhea
paralyt
ileu
may
occur
kd
mimic
acut
surgic
abdomen
especi
older
children
patient
extrem
irrit
due
asept
mening
present
signific
number
children
seizur
loss
conscious
may
occur
occasion
sensorineur
hear
loss
facial
nerv
palsi
describ
usual
perman
testicular
swell
tender
urethr
meatiti
may
occur
steril
pyuria
also
present
increas
leucocyt
urinari
sediment
late
renal
arteri
stenosi
aneurysm
dilat
lead
system
hypertens
children
cough
tachypnea
may
occur
due
pneumon
pulmonari
infiltr
effus
bullou
vesicular
rash
gener
lymphadenopathi
differenti
diagnosi
viral
infect
scarlet
fever
staphylococc
scald
skin
syndrom
toxic
shock
syndrom
bacteri
cervic
lymphaden
drug
hypersensit
reaction
stevenjohnson
syndrom
juvenil
rheumatoid
arthriti
rocki
mountain
spot
fever
leptospirosi
acrodynia
must
kept
mind
fulfil
clinic
criteria
tabl
consid
diagnost
kawasaki
diseas
patient
must
fever
least
day
newer
recommend
fever
least
day
durat
addit
least
criteria
need
diagnosi
kd
tabl
symptom
develop
simultan
may
take
day
syndrom
develop
henc
patient
assess
repeatedli
kd
diagnos
patient
fever
unknown
origin
sourc
fever
exanthem
etc
present
famili
histori
kd
symptom
suggest
kd
consid
risk
factor
kd
clinic
criteria
fever
least
day
durat
polymorph
exanthema
bilater
bulbar
conjunctiva
inject
oral
caviti
lip
chang
chang
extrem
swell
palm
sole
membran
desquam
convalesc
stage
cervic
lymphadenopathi
greater
cm
diamet
leucocytosi
elev
neutrophil
mark
thrombocytosi
rare
thrombocytopenia
normocyt
normochrom
anemia
elev
acut
phase
reactant
esr
crp
seen
kd
mild
hypoalbuminemia
mild
increas
serum
transaminas
steril
pyuria
may
seen
find
gradual
decreas
therapi
immunoglobulin
diagnost
supplement
laboratori
criteria
tabl
throat
cultur
antistreptolysino
titer
evalu
diseas
mimic
kd
must
made
prior
immunoglobulin
therapi
week
onset
ill
complet
blood
count
differenti
crp
esr
recommend
lipid
profil
evalu
one
year
followup
period
thereaft
cardiac
catheter
coronari
angiographi
allow
detect
distal
coronari
aneurysm
seen
echocardiogram
coronari
arteri
obstruct
either
thrombu
stenosi
also
allow
therapeut
option
intralumin
thrombolyt
therapi
thrombu
percutan
translumin
coronari
angioplasti
ptca
stenosisi
aortogram
also
indic
first
studi
patient
detect
involv
blood
vessel
aneurysm
format
catheter
indic
month
onset
kd
earlier
necessari
patient
aneurysm
advantag
mri
ct
imag
modal
noninvas
natur
excel
techniqu
supplement
studi
modal
togeth
help
detect
distal
aneurysm
intravascular
chang
thrombi
occlus
intim
hypertrophi
calcif
also
help
detect
involv
arteri
coronari
blood
vessel
peak
incid
develop
aneurysm
week
onset
diseas
past
decad
sever
risk
factor
identifi
associ
higher
incid
coronari
arteri
aneurysm
format
includ
famili
histori
kd
age
less
one
male
gender
fever
longer
day
durat
doubl
spike
fever
hemoglobin
concentr
hematocrit
white
cell
count
platelet
count
esr
westergren
mmhour
serum
sodium
level
meql
sl
serum
albumin
g
l
base
laboratori
valu
variou
score
system
develop
predict
risk
develop
aneurysm
valid
high
dose
asa
start
mgkgday
four
divid
dose
continu
hour
cessat
fever
gastriti
may
develop
henc
asa
given
prefer
meal
high
dose
low
dose
asa
antiplatelet
dose
mgkgday
begun
continu
till
month
onset
diseas
demonstr
evid
coronari
abnorm
echocardiogram
coronari
abnorm
detect
low
dose
asa
continu
indefinit
ibuprofen
avoid
children
asa
antagon
platelet
inhibit
induc
asa
rey
syndrom
report
kd
children
asa
henc
asa
withheld
exposur
either
influenza
varicella
patient
may
annual
vaccin
influenza
vaccin
hold
asa
switch
anoth
antiplatelet
agent
week
vaccin
singl
infus
wig
given
dose
gkg
addit
asa
acut
phase
within
day
onset
fever
may
given
even
day
onset
diseas
fever
persist
aneurysm
develop
elev
esrcrp
present
earli
treatment
ivig
within
day
ill
associ
need
ivig
retreat
tm
exact
mechan
action
wig
reduc
preval
coronari
arteri
abnorm
acut
phase
reaction
known
number
mechan
may
play
includ
decreas
cytokin
product
blockad
fc
receptor
neutral
antigen
revers
immunoregulatori
abnorm
increas
suppressor
cell
decreas
b
lymphocyt
inhibit
complementmedi
lysi
use
ivig
treat
kd
though
best
avail
therapi
ideal
form
therapi
despit
adequ
treatment
nearli
children
develop
transient
coronari
dilat
giant
coronari
aneurysm
addit
ivig
blood
product
carri
risk
allerg
reaction
serum
sick
risk
blood
born
pathogen
live
vaccin
defer
month
wig
therapi
steroid
therapi
earli
phase
kd
current
trial
recent
interest
use
abciximab
larg
aneurysm
therapi
anticytokin
agent
infliximab
pentoxifyllin
also
report
failur
respond
wig
therapi
persist
fever
reappear
fever
hour
complet
infus
constitut
immunoglobulinresist
seen
case
risk
develop
coronari
arteri
lesion
popul
high
respond
wig
refractori
may
reflect
genet
variat
patient
popul
variabl
agent
caus
kd
may
quantiti
antiinflammatori
factor
ivig
vari
one
pool
second
third
even
fourth
dose
ivig
mayb
need
quell
inflammatori
cascad
three
factor
seen
associ
immunoglobulin
resist
kd
crp
mgdl
lactat
dehydrogenas
iul
hemoglobin
concentr
fever
persist
dose
ivig
puls
steroid
therapi
may
initi
use
intraven
methylprednisolon
mg
kg
hour
daili
day
taper
risk
associ
therapi
commonli
includ
leucocytosi
hyperglycemia
hypertens
rare
seizur
intraven
heparin
given
along
methylprednisolon
especi
coronari
arteri
lesion
sinc
steroid
may
increas
thrombogen
altern
low
dose
steroid
regimen
use
center
intraven
methypredinsolon
mgkgday
divid
dose
one
day
follow
taper
dose
oral
prednison
day
week
center
routin
use
infliximab
refractori
kd
although
therapi
still
experiment
report
therapeut
modal
includ
plasma
exchang
cyclophosphamid
cyclosporin
ulinastatin
whichev
therapi
use
patient
period
monitor
progress
coronari
arteri
lesion
echocardiographi
sign
continu
inflamm
crp
andor
esr
coronari
arteri
aneurysm
identifi
import
prevent
thrombosi
aneurysm
due
anatom
hematolog
immunolog
factor
factor
togeth
put
children
high
risk
form
thrombu
lead
coronari
arteri
occlus
anatom
factor
sluggish
blood
flow
dilat
segment
develop
stenosi
inlet
aneurysm
proxim
distal
coronari
obstruct
signific
increas
number
platelet
acut
subacut
phase
may
also
contribut
thrombosi
immunolog
factor
includ
activ
platelet
endothelium
make
blood
hypercoagul
patient
antiplatelet
therapi
recommend
least
lesion
regress
addit
antiplatelet
therapi
anticoagul
recommend
children
multipl
complex
aneurysm
singl
aneurysm
mm
size
preval
antiplatelet
therapi
asa
mgkgday
clopidogrel
dipyridamol
may
given
addit
asa
suppress
platelet
activ
high
risk
patient
clopidogrel
alon
also
recommend
kd
asa
toler
contraind
initi
intraven
unfraction
heparin
done
warfarin
dose
lead
therapeut
level
intern
normal
ratio
inr
warfarin
replac
low
molecular
weight
heparin
target
antifactor
xa
level
uml
especi
infant
monitor
inr
difficult
pregnant
femal
contraind
either
intraven
direct
intracoronari
infusiow
via
catheter
fibrinolyt
agent
indic
restor
patenc
coronari
arteri
streptokinas
tissu
plasminogen
activ
urokinas
may
use
addit
asa
heparin
therapi
agent
inhibit
platelet
aggreg
found
lower
rate
reocclus
reinfarct
adult
coronari
arteri
diseas
given
along
fibrinolyt
therapi
abciximab
report
enhanc
vascular
remodel
hasten
reduct
aneurysm
size
restor
patenc
coronari
arteri
acut
set
also
achiev
angioplasti
without
stent
placement
cardiac
catheter
intervent
intervent
ptca
rotat
ablat
stent
perform
success
kd
children
stenosi
coronari
renal
arteri
cathet
intervent
recommend
ischem
symptom
without
ischem
symptom
revers
ischemia
stress
test
stenosi
left
anterior
descend
coronari
arteri
tm
angioplasti
lesion
year
acut
phase
kd
less
success
earli
detect
coronari
arteri
stenosi
intervent
ptca
fibrosi
minim
lesion
yet
calcifi
may
optim
manag
kd
older
stenot
lesion
stiff
calcifi
use
low
pressur
balloon
stent
placement
recommend
prevent
neoaneurysm
format
ptca
achiev
balloon
pressur
atm
rotat
ablat
coronari
arteri
bypass
graft
cabg
surgeri
indic
cabg
procedur
recommend
patient
revers
ischemia
associ
longseg
stenosi
ostial
stenosi
multipl
stenosi
sever
occlus
left
main
coronari
arteri
left
anterior
descend
coronari
arteri
sever
occlus
greater
one
major
coronari
arteri
collater
coronari
arteri
jeopardi
recurr
myocardi
infarct
sever
left
ventricular
dysfunct
stenot
lesion
occur
proxim
segment
coronari
vessel
henc
graft
site
easili
access
arteri
graft
prefer
venou
graft
due
growth
potenti
longer
patenc
rate
offer
sever
irrevers
ischemia
lesion
improv
cathet
intervent
cabgi
low
risk
children
without
coronari
arteri
abnorm
complet
resolut
transient
ectasia
within
month
onset
kd
may
discontinu
asa
return
normal
physic
activ
invas
test
recommend
children
assess
counsel
atherosclerot
risk
everi
year
interv
coronari
aneurysm
high
risk
patient
physic
activ
beyond
month
acut
kd
especi
older
children
year
guid
stress
testsperfus
scan
contact
sport
avoid
annual
twice
year
mm
aneurysm
multipl
aneurysm
cardiovascular
risk
assess
perform
assess
risk
factor
prematur
atherosclerosi
echocardiogram
ecg
stress
testmyocardi
perfus
scan
angiographi
indic
ischemia
detect
noninvas
test
betablockad
therapi
recommend
reduc
myocardi
oxygen
consumpt
coronari
arteri
specul
coronari
microvascular
lesion
may
underli
factor
persist
sequela
kd
loss
endotheli
reactiv
patient
episod
kawasaki
diseas
indic
enhanc
stiff
coronari
vessel
alter
lipid
profil
also
found
patient
mani
year
diseas
suggest
damag
coronari
endotheli
cell
persist
kawasaki
diseas
regardless
angiograph
coronari
sequela
assess
plasma
level
thrombomodulin
coronari
venou
blood
cartilagin
metaplasia
coronari
arteri
wall
long
term
survivor
kawasaki
diseas
manifest
ring
calcif
grow
belief
carotid
intimamedia
thick
cimt
echocardiogram
regard
indic
gener
atherosclerosi
increas
cimt
detect
kd
measur
ultrasensit
crp
marker
acut
phase
reaction
help
detect
ongo
inflamm
tissu
bodi
increas
level
detect
kd
mani
year
diseasey
loss
endotheli
vasoreact
ongo
vascul
proatherogen
lipid
profil
probabl
risk
factor
acceler
atherosclerosi
may
lead
prematur
atherosclerosi
ischem
heart
diseas
popul
atherosclerosi
nonspecif
respons
blood
vessel
chronic
injuri
may
infecti
immun
etiolog
prolif
respons
regul
endothelium
mediat
nitric
oxid
postmortem
studi
demonstr
inflammatori
insult
endothelium
coronari
arteri
wall
creat
focu
subsequ
acceler
atherosclerosi
thu
kd
popul
monitor
regular
interv
risk
factor
atherosclerosi
especi
prior
histori
coronari
aneurysm
weight
manag
avoid
smoke
sedentari
lifestyl
high
cholesterol
food
stress
period
evalu
blood
pressur
lipid
profil
adipos
also
made
hallmark
kd
involv
system
blood
vessel
along
inflamm
endotheli
activ
acut
phase
reaction
mark
immun
activ
increas
thrombogen
etiolog
kd
remain
unknown
recognit
diseas
earli
treatment
paramount
import
avoid
coronari
arteri
complic
diagnos
treat
earli
high
dose
intraven
immunoglobulin
patient
mild
cours
without
coronari
arteri
aneurysm
format
neglig
occurr
earli
acut
myocardi
infarct
howev
despit
therapi
patient
develop
ectasia
develop
coronari
aneurysm
immunoglobulin
resist
incomplet
form
kd
continu
remain
challeng
problem
damag
coronaryvasculatur
kawasaki
diseas
appear
longterm
sequela
necessit
life
long
monitor
even
aneurysm
regress
